Strategies for combining immunotherapy with radiation for anticancer therapy

Area of Science:

• Oncology
• Immunology
• Radiotherapy

Background:

• Radiation therapy effectively controls localized cancer but can also stimulate systemic anti-tumor immunity.
• The abscopal effect, characterized by regression of non-irradiated tumors following local radiation, is mediated by immune responses.
• Immune checkpoint pathways often suppress anti-tumor immune responses, limiting the efficacy of radiation-induced abscopal effects.

Purpose of the Study:

• To explore strategies for enhancing radiation-induced abscopal effects.
• To investigate the potential of combining radiation therapy with immunotherapies.
• To evaluate novel approaches for improving systemic anti-tumor immunity in cancer patients.

Main Methods:

• Review of preclinical and clinical studies investigating radiation therapy combined with immunotherapies.
• Analysis of studies using immune checkpoint inhibitors (e.g., anti-CTLA4) with radiation.
• Examination of adoptive cell transfer strategies (T cells, NK cells, engineered T cells) in conjunction with radiation.

Main Results:

• Abscopal responses have been observed in lung cancer and melanoma patients treated with radiation and anti-CTLA4 antibody.
• Adoptive immunotherapies, including T cell or NK cell infusions, show promise for enhancing abscopal effects.
• Engineered T cells targeting specific tumor antigens may offer a therapeutic avenue, particularly for immunocompromised patients.

Conclusions:

• Combining radiation therapy with immune checkpoint blockade or adoptive cell transfer can enhance systemic anti-tumor immunity and abscopal responses.
• These combination strategies hold significant potential for improving cancer treatment outcomes.
• Further clinical trials are warranted to optimize and validate these immunoradiotherapy approaches.